MedPath
TGA Approval

BUPIVACAINE 0.5% WITH ADRENALINE 1:200,000 PHEBRA bupivacaine HCl 100 mg/20 mL with adrenaline 100 microgram/20 mL solution for injection vial (373819)

373819

BUPIVACAINE 0.5% WITH ADRENALINE 1:200,000 PHEBRA bupivacaine HCl 100 mg/20 mL with adrenaline 100 microgram/20 mL solution for injection vial

Phebra Pty Ltd

October 7, 2022

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2022-CMI-02113-1

Product Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2022-PI-02111-1

Active Ingredients

bupivacaine hydrochloride monohydrate

adrenaline (epinephrine) acid tartrate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

BUPIVACAINE 0.5% WITH ADRENALINE 1:200,000 PHEBRA bupivacaine HCl 100 mg/20 mL with adrenaline 100 microgram/20 mL solution for injection vial (373819) - TGA 批准文号 | MedPath